Resumo

BELTRAN GARATE, Brady  e  YABAR BERROCAL, Alejandro. Expresión de HER2 en cancer gástrico en el Perú: HER2 expression in gastric cancer in Peru. Rev. gastroenterol. Perú [online]. 2010, vol.30, n.4, pp.324-327. ISSN 1022-5129.

HER2 positivity is thought to be a negative prognostic factor in gastric cancer (GC), correlating with poor survival rates. Reported HER2-positivity rates in GC have varied widely (6-35%).Objetive of this study is to determine rate of positivity and describe clinical and pathological characteristics of HER-2(+) GC. 100 GC tumour samples were centrally screened by immunohistochemistry and FISH. 9% of cases were positive. More positivity HER2 was found in advanced stages (III/IV) vs. early stages (I/II)(p=0.045) ; intestinal histology subtype vs diffuse/ mixed (p=0.045) and gastro-oesophageal junction cancer vs GC ( p=0.005).

Palavras-chave : Gastric cancer; prognostic factors; oncogens.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )